Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Upgrades

Upgrades

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • General
  • Markets
  • News
  • Trading Ideas
  • Upgrades

Analyst Upgrades Homebuilders In Anticipation Of A Credit Catalyst Amid Recession Fears

By Shivani Kumaresan
November 2, 3:27 PM
Seaport analyst Kenneth Zener has upgraded the shares of KB Home (NYSE: KBH), M.D.C.

KBH

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Movers
  • Price Target
  • Trading Ideas
  • Upgrades

Amgen Wins Big With FDA, Analyst Sees Soaring Potential

By Priya Nigam
November 2, 3:01 PM
The FDA approval of Amgen, Inc’s (NASDAQ: AMGN) biosimilar version of Johnson & Johnson's (NYSE: JNJ) psoriasis treatment, Stelara, for multiple inflammatory diseases sent

AMGN

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • Large Cap
  • Markets
  • News
  • Price Target
  • Trading Ideas
  • Upgrades

Analyst Sees Over €10B Annual FCF For Stellantis, Despite Forecasting Lower Earnings In FY24-25

By Lekha Gupta
November 1, 3:42 PM
Bernstein analyst Daniel Roeska upgraded Stellantis N.V. (NYSE: STLA) to Outperform from Market-Perform at an increased price target of 

STLA

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • General
  • Markets
  • News
  • Price Target
  • Trading Ideas
  • Upgrades

Barclays Upgrades Both Ford And General Motors To Overweight But Prefers GM Over Ford

By Shivani Kumaresan
November 1, 2:38 PM
Barclays analyst Dan Levy upgraded the rating on Ford Motor Company (NYSE: F) and General Motors Company (NYSE: GM) from Equal-Weight to Overweight with a 

F

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • Equities
  • Large Cap
  • Markets
  • Mid Cap
  • News
  • Price Target
  • Real Estate
  • REIT
  • Trading Ideas
  • Upgrades

Real Estate REITs Pressured Amid Higher Interest Rate & Supply Woes, But Analyst Upgrades AvalonBay Communities: Here’s Why

By Lekha Gupta
October 31, 2:38 PM
Piper Sandler analyst Alexander Goldfarb revised ratings on several real estate REITs amid higher interest rates environment and increased supply pressures scenario.

AVB

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • Markets
  • Mid Cap
  • News
  • Price Target
  • Trading Ideas
  • Upgrades

Chewy Gets A Bite Of Confidence: Morgan Stanley Upgrades To Overweight Despite Market Gloom

By Lekha Gupta
October 31, 2:25 PM
Morgan Stanley analyst Lauren Schenk upgraded Chewy Inc (NYSE: CHWY) to Overweight from Equal-Weight at a lowered 

CHWY

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Price Target
  • Upgrades

Invitation Homes Is An ‘Attractive 2024 Story,’ Says This Bullish Analyst

By Priya Nigam
October 30, 3:16 PM
Invitation Homes Inc (NYSE: INVH) shares are on course to exit October with losses of around 7%. Rent growth and occupancy are normalizing and should remain above the pre-COVID-19 pandemic averages in 2024, according to Oppenheimer.

INVH

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • Large Cap
  • Markets
  • News
  • Price Target
  • Trading Ideas
  • Upgrades

L3Harris Technologies On Path To Financial Normalization, Analyst Upgrades Stock

By Lekha Gupta
October 30, 2:19 PM
Raymond James analyst Brian Gesuale upgraded L3Harris Technologies Inc (NYSE: LHX) to Outperform from Market Perform and established a 

LHX

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Price Target
  • Upgrades

PTC Analyst Turns Bullish, As Stock Trades At Discount To Peers

By Priya Nigam
October 30, 12:30 PM
Shares of PTC Inc. (NASDAQ: PTC) were climbing in early trading on Monday, just weeks after the company acquired Pure-Systems.

PTC

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Commodities
  • Markets
  • Price Target
  • Upgrades

Chevron Stock Pullback Wipes Out 90% Of Hess Value, But This Bullish Analyst Says ‘Buy’

By Priya Nigam
October 30, 12:01 PM
Chevron Corporation (NYSE: CVX) shares recovered slightly in early trading on Monday, after tanking on disappointing third-quarter earnings.

CVX

Posts pagination

Previous 1 … 26 27 28 … 188 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service